Compare ILMN & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | EL |
|---|---|---|
| Founded | 1998 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 30.3B |
| IPO Year | 2000 | 2007 |
| Metric | ILMN | EL |
|---|---|---|
| Price | $190.46 | $82.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 20 |
| Target Price | ★ $124.24 | $97.60 |
| AVG Volume (30 Days) | 1.9M | ★ 3.0M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | ★ 170.87 | N/A |
| EPS | ★ 0.87 | 0.82 |
| Revenue | $4,343,000,000.00 | ★ $14,326,000,000.00 |
| Revenue This Year | $6.47 | $7.51 |
| Revenue Next Year | $5.58 | $4.08 |
| P/E Ratio | $213.44 | ★ $101.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $88.00 | $66.22 |
| 52 Week High | $196.66 | $121.64 |
| Indicator | ILMN | EL |
|---|---|---|
| Relative Strength Index (RSI) | 51.53 | 52.20 |
| Support Level | $116.54 | $80.76 |
| Resistance Level | $196.66 | $87.57 |
| Average True Range (ATR) | 6.46 | 2.58 |
| MACD | -1.84 | 0.12 |
| Stochastic Oscillator | 24.03 | 57.26 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top-selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.